| Popis: |
Purpose of the study was to determine the pharmacotherapy of systemic autoimmune diseases with hyperimmunocomplex syndrome based on ABC/VEN analysis of drugs according to the ATC code C05SH. Among the systemic autoimmune diseases are systemic lupus erythematosus, systemic vasculitis, psoriasis, rheumatoid arthritis. Pharmacoeconomic methods of analysis, in particular ABC/VEN analysis, are used to select effective and safe drugs Important tasks of pharmacotherapy of systemic autoimmune diseases include the study of immune-dependent complexes on the background of hyperimmunocomplex syndrome. Circulating immune complexes are eliminated by phagocytosis through the spleen, lungs, kidneys and liver. Therefore, the main task of pharmacotherapy of systemic autoimmune diseases with hyperimmunocomplex syndrome is to control the functions of these organs and systems. Marketing research of drugs by INN Quercetin of the ATC-code C05CX by assortment, countries-manufacturers, dosage forms, registration certificates was carried out. Pharmacoeconomic studies have been conducted. According to the results of ABC analysis, drugs by INN Quercetin of the ATC-code C05CX were distributed in descending order of value. It is proved that group A (the most expensive in price) included 77.4% of drugs from the total number of doctor's appointments. According to the results of VEN-analysis by INN Quercetin of the ATC-code C05CX, it is calculated that all drugs are recommended to be included as non-essential. Drugs for group N occupy the highest financial costs prescribed by doctors for pharmacotherapy (100%). The niche of the A/N matrix has the highest indicator for doctors' appointments and financial expenses (77.4%). The results of the study provide an opportunity to make administrative and managerial decisions in determining the pharmacotherapy of systemic autoimmune diseases with hyperimmunocomplex syndrome to improve the use of drugs in hospitals. |
